Immunocytochemical evidence for differential subcellular localization of 5α-reductase isoenzymes in human tissues

Acta Anatomica

Volumn 156, Issue 4, 1997, Pages 241-252

  Aumuller G ^a   Eicheler, W ^a   Renneberg, H ^a   Adermann, K ^b   Vilja, P ^b   Forssmann, W G ^b  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

^b IPF PHARMACEUTICALS GMBH   (Germany)

Author keywords

5 Reductases 1 and 2; Androgen receptor; Immunohistochemistry; Peptide fragments, synthetic; Western blotting

Indexed keywords

ISOENZYME; OXIDOREDUCTASE;

ANIMAL EXPERIMENT; ARTICLE; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOCYTOCHEMISTRY; IMMUNOHISTOCHEMISTRY; NONHUMAN; PRIORITY JOURNAL; PROSTATE; RABBIT;

AMINO ACID SEQUENCE; BLOTTING, WESTERN; CELL NUCLEUS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; ISOENZYMES; MALE; MOLECULAR SEQUENCE DATA; PEPTIDE FRAGMENTS; PLACENTA; PREGNANCY; PROSTATE; SEMINAL VESICLES; TESTOSTERONE 5-ALPHA-REDUCTASE; TISSUE DISTRIBUTION;

EID: 0031018808     PISSN: 00015180     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (57)

1. Abalain, J.H., E. Quemener, J.L. Carre, B. Simon, Y. Amet, P. Mangin, H.H. Floch (1989) Metabolism of androgens in human hyperplastic prostate: Evidence for a differential localization of the enzymes involved in the metabolism. J Steroid Biochem 34: 467-471.
2. Adermann, K., P. Vilja, M. Kuhn, S. Austermann, W.G. Forssmann (1994) Aspects of synthesis and analysis of multiple antigen peptides; in Epton R (ed): Innovation and Perspectives in Solid Phase Synthesis. Peptides, Proteins and Nucleic Acids - Biological and Biomedical Applications. Oxford, Mayflower Worldwide, pp 429-432.
3. Andersson, S., D.M. Berman, E.P. Jenkins, D.W. Russell (1991) Deletion of steroid 5α-reductase 2 gene in male pseudohermaphroditism. Nature 354: 159-161.
4. Andersson, S., D.W. Russell (1990) Structural and biochemical properties of cloned and expressed human and rat steroid 5α-reductases. Proc Natl Acad Sci 87: 3640-3644.
5. Aumüller, G., H. Renneberg, L. Konrad, S. Groos, P.M. Holterhus (1996) Immunohistochemistry of 5α-reductase isoenzymes and steroid hormone receptors during development of the human prostate (abstract). Exp Clin Endocrinol Diabetes 104(suppl 1): 79.
6. Bläuer, M., A. Vaalasti, S.L. Pauli, T. Ylikomi, T. Joensuu, P. Tuohimaa (1991) Location of androgen receptor in human skin. J Invest Dermatol 97: 264-268.
7. Bradford, M. (1976) A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254.
8. Clark, J.H., E.J. Peck, Jr. (1979) Monographs on Endocrinology: Female Sex Steroids. Heidelberg, Springer, pp 150-167.
9. Dijkstra, A., C.M.A.A. Goos, W.J. Cunliffe, C. Sultan, A.J.M. Vermorken (1988) Is increased 5α-reductase activity a primary phenomenon in androgen dependent skin disorders? J Invest Dermatol 89: 87-92.
10. Eicheler, W., G. Aumüller, R. Happle, R. Hoffmann (1996) Immunolocalization of steroid 5α-reductase isoenzymes in human fetal skin. Eur J Dermatol 6: 132-134.
11. Eicheler, W., M. Bacher, J. Seitz, K. Adermann, W.G. Forssmann, L. Jacob, G. Aumüller (1992) Characterization and tissue distribution of 5α-reductase using a polyclonal antibody; in Spera G, A Fabrini, L Gnessi, CW Bardin (eds): Molecular and Cellular Biology of Reproduction. New York, Raven Press, pp 257-267.
12. Eicheler, W., M. Dreher, R. Hoffmann, R. Happle, G. Aumüller (1995) Immunohistochemical evidence for differential distribution of 5α-reductase isoenzymes in human skin. Br J Dermatol 133: 371-376.
13. Eicheler, W., P. Tuohimaa, P. Vilja, K. Adermann, W.G. Forssmann, G. Aumüller (1994) Immunocytochemical localization of human 5α-reductase 2 with polyclonal antibodies in androgen target and non-target human tissues. J Histochem Cytochem 42: 667-675.
14. Enderle-Schmitt, U., E. Völck-Badouin, J. Schmitt, G. Aumüller (1986) Functional characteristics of nuclear 5α-reductase from rat ventral prostate. J Steroid Biochem 25: 209-217.
15. Fitzpatrick, F.A., G.L. Bundy (1978) Hapten mimic elicits antibodies recognizing prostaglandin E2. Proc Natl Acad Sci 75: 2689-2693.
16. Gaston, K., M. Fried (1992) The isolation of transcription factors from λ gt11 cDNA expression libraries: Human steroid 5α-reductase 1 has sequence-specific DNA binding activity. Nucleic Acid Res 20: 6297-6301.
17. Hiipakka, R.A., M. Wang, T. Bloss, K. Ito, S. Liao, (1993) Expression of 5α-reductase in bacteria as a trp E fusion protein and its use in the production of antibodies for immunocytochemical localization of 5α-reductase. J Steroid Biochem Mol Biol 45: 539-548.
18. Horton, R., D. Hawks, R. Lobo (1986) 3α-17β-androstanediol glucuronide in plasma: A marker of androgen action in idiopathic hirsutism. J Clin Invest 69: 1203-1206.
19. Houston, B., G.D. Chisholm, F.K. Habib (1985) Evidence that human prostatic 5α-reductase is located exclusively in the nucleus. FEBS Lett 185: 231-235.
20. Hudson, R.W. (1987) Comparison of nuclear 5α-reductase activities in the stromal and epithelial fractions of human prostatic tissue. J Steroid Biochem 26: 349-353.
21. Ichihara, K., C. Tanaka (1991) Phospholipid requirement of progesterone 5α-reductase from gastric mucosa microsomes of guinea pig. Lipids 26: 531-535.
22. Imperato-McGinley, J., L. Guerrero, T. Gautier, R.E. Peterson (1974) Steroid 5α-reductase deficiency in man: An inherited form of male pseudohermaphroditism. Science 186: 1213-1215.
23. Jenkins, E.P., S. Andersson, J. Imperato-McGinley, J.D. Wilson, D.W. Russell (1992) Genetic and pharmacological evidence for more than one human steroid 5α-reductase. J Clin Invest 89: 293-300.
24. Kaufman, M., L. Pinsky, M. Trifiro, R. Lumbroso, N. Sabbaghian, B. Gottlieb (1993) Kinetic evidence for a unique testosterone receptor complex in 5α-reductase sufficient genital skin fibroblasts and the effects of 5α-reductase deficiency of its formation. J Steroid Biochem Mol Biol 45: 467-476.
25. Kimura, N., A. Mizikami, T. Oonuma, H. Sasano, H. Nagura (1993) Immunocytochemical localization of androgen receptor with polyclonal antibody in paraffin-embedded human tissues. J Histochem Cytochem 41: 671-678.
26. Laemmli, U.K. (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227: 680-685.
27. Lephart, E.D., K.J. Doody, M.J. McPhaul, E.R. Simpson (1992) Inverse relationship between ovarian aromatase cytochrome P450 and 5α-reductase enzyme activities and mRNA levels during the estrous cycle in the rat. J Steroid Biochem Mol Biol 42: 439-447.
28. Liang, T., S. Hoyer, R. Yu, K. Soltani, A.L. Lorincz, R.A. Hiipakka, S. Liao (1993) Immunocytochemical localization of androgen receptors in human skin using monoclonal antibodies against the androgen receptor. J Invest Dermatol 100: 663-666.
29. Liao, S., T. Liang, S. Fang, E. Castaneda, T.C. Shao (1973) Steroid structure and androgenic activity. Specificities involved in the receptor binding and nuclear retention of various androgens. J Biol Chem 248: 6154-6161.
30. Martini, L., R. Melcangi (1991) Androgen metabolism in the brain. J Steroid Biochem Mol Biol 39: 819-828.
31. Melcangi, R.C., F. Celotti, P. Castanao, L. Martini (1993) Differential localization of the 5α-reductase and the 3α-hydroxysteroid dehydrogenase in neuronal and glial cultures. Endocrinology 132: 1252-1259.
32. Miyamoto, T., S. Kagawa, K. Kitagawa, S. Futaki, H. Yokoi, Y. Tsuruo, K. Ishimura (1996) Immunocytochemical localization of 5α-reductase type 1 in the prostate of normal and castrated rats. Histochem Cell Biol 105: 101-109.
33. Moore, R.J., J.D. Wilson (1973) The effect of androgenic hormones on the reduced nicotin-amide adenine dinucleotide phosphate: Δ4-3-ketosteroid 5α-oxidoreductase of rat ventral prostate. Endocrinology 93: 581-592.
34. Morfin, R.B., J.P. Bercovivi, J.F. Charles, H.H. Floch (1975) Testosterone and progesterone metabolism and their interaction in the human hyperplastic prostate. J Steroid Biochem 6: 1347-1353.
35. Normington, K., D.W. Russell (1992) Tissue distribution and kinetic characteristics of rat steroid 5α-reductase isozymes - Evidence for distinct physiological functions. J Biol Chem 267: 16548-16554
36. Petrow, V. (1986) The dihydrotestosterone (DHT) hypothesis of prostate cancer and its therapeutic implications. Prostate 9: 343-361.
37. Quemener, E., Y. Amet, S. di Stefano, G. Fournier, H. Floch, J.-H. Abalain (1994a) Purification of testosterone 5α-reductase from human prostate by a four-step chromatographic procedure. Steroids 59: 712-718.
38. Quemener, E., Y. Amet, G. Fournier, S. di Stefano, J.-H. Abalain, H.-H. Floch (1994b) Glycosylated nature of testosterone 5α-reductase 2 purified from human prostate. Biochem Biophys Res Commun 205: 269-274.
39. Rennie, P.S., N. Bruchovsky, M.G. McLoughlin, F.H. Batzold, E.E. Dunstan-Adams (1983) Kinetic analysis of 5α-reductase isoenzymes in benign prostatic hyperplasia (BPH). J Steroid Biochem 19: 169-173.
40. Rittmaster, R.S., H. Uno, M.L. Povar, T.N. Mellin, D.L. Loriaux (1987) The effects of N, N-diethyl-4-methyl-3-oxo-4-aza-5 alpha-androstane-17 beta-carboxamide, a 5α-reductase inhibitor and anti-androgen, on the development of baldness in the stumptail macaque. J Clin Endocrinol Metab 65: 188-193.
41. Ruizeveld de Winter, J.A., J. Trapman, M. Vermey, E. Mulder, N.D. Zegers, T.H. van der Kwast (1991) Androgen receptor expression in human tissues: An immunological study. J Histochem Cytochem 39: 927-936.
42. Silver, R.I., E.L. Wiley, D.L. Davis, A.E. Thigpen, D.W. Russell, J.D. McConnell (1994a) Expression and regulation of steroid 5α-reductase 2 in prostate disease. J Urol 152: 433-437.
43. Silver, R.I., E.L. Wiley, A.E. Thigpen, J.M. Guileyardo, J.D. McConnell, D.W. Russell (1994b) Cell type specific expression of steroid 5α-reductase 2. J Urol 152: 438-442.
44. Sternberger, L.A., P.H. Hardy, Jr., J.J. Cuculis, H.G. Meyer (1970) The unlabeled antibody enzyme method of immunohistochemistry. J Histochem Cytochem 18: 315-333.
45. Tam, J.P. (1988) Synthetic peptide vaccine design: Synthesis and properties of a high density multiple antigenic peptide system. Proc Natl Acad Sci 85: 5409-5413.
46. The Finasteride Study Group (1993) Finasteride (MK-906) in the treatment of benign prostatic hyperplasia. Prostate 22: 291-299.
47. Thigpen, A.E., K.M. Cala, D.W. Russell (1993a) Characterization of Chinese hamster ovary cell lines expressing human steroid 5α-reductase isozymes. J Biol Chem 268: 17404-17412.
48. Thigpen, A.E., D.L. Davis, A. Milatovich, B.B. Mendoca, J. Imperato-McGinley, J.E. Griffin, U. Francke, J.D. Wilson, D.W. Russell (1992) Molecular genetics of steroid 5α-reductase deficiency. J Clin Invest 90: 799-809.
49. Thigpen, A.E., R.I. Silver, J.M. Giuleyardo, M.L. Casey, J.D. McConnell, D.W. Russell (1993b) Tissue distribution and ontogeny of steroid 5α-reductase isozyme expression. J Clin Invest 92: 903-909.
50. Towbin, H., T. Staehelin, J. Gordon (1979) Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: Procedure and some applications. Proc Natl Acad Sci 76: 4350-4354.
51. Trapp, T., S. Tunn, M. Krieg (1992) Purification and properties of the 5α-dihydrotestosterone 3α(β)-hydroxysteroid dehydrogenase from human prostatic cytosol. J Steroid Biochem Mol Biol 42: 321-327.
52. Tunn, S., H. Hochstrate, I. Grunwald, S. Flüchter, M. Krieg (1988) Effect of aging on kinetic parameters of 5α-reductase in epithelium and stroma of normal and hyperplastic human prostate. J Clin Endocrinol Metab 67: 979-985.
53. Viger, R.S., B. Robaire (1991) Expression of 4-ene steroid 5α-reductase messenger ribonucleic acid in the rat epididymis during postnatal development. Endocrinology 131: 1534-1540.
54. Viger, R.S., B. Robaire (1996) The mRNAs for the steroid 5α-reductase isoenzymes, types 1 and 2, are differentially regulated in the rat epididymis. J Androl 17: 27-34.
55. Voigt, W., E.P. Fernandez, S.L. Hsia (1970) Transformation of testosterone into 17β-hydroxy-5α-androstan-3-one by microsomal preparations of human skin. J Biol Chem 245: 5594-5599.
56. Weisser, H., S. Tunn, M. Debus, M. Krieg (1994) 5α-reductase inhibition by finasteride (Proscar®) in epithelium and stroma of human benign prostatic hyperplasia. Steroids 59: 616-620.
57. Wise, L.D., D.H. Minsker, M.A. Cubierski, R.L. Clark, S. Prahalada, J.M. Antonello, J.S. MacDonald, R.T. Robertson (1991) Reversible decreases of fertility in male Sprague-Dawley rats treated orally with finasteride, a 5α-reductase inhibitor. Reprod Toxicol 5: 337-346.